Suven Pharmaceuticals informs about credit rating

28 Feb 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Suven Pharmaceuticals has informed that the CRISIL has assigned/ reaffirmed the ratings to the Bank facilities of the Company as per letter received on February 28, 2025. The said letter is annexed.

The above information is a part of company’s filings submitted to BSE.

Cohance Lifesciences Share Price

295.80 0.00 (0.00%)
11-Mar-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.10
Dr. Reddys Lab 1313.70
Cipla 1343.85
Zydus Lifesciences 923.95
Lupin 2350.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×